tiprankstipranks
Synopsys (SNPS)
NASDAQ:SNPS
Want to see SNPS full AI Analyst Report?

Synopsys (SNPS) AI Stock Analysis

5,237 Followers

Top Page

SNPS

Synopsys

(NASDAQ:SNPS)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
$492.00
▲(9.44% Upside)
Action:ReiteratedDate:04/21/26
The score is driven primarily by strong cash generation and solid operating performance, reinforced by a positive earnings update (raised non-GAAP EPS guidance and strong backlog). These positives are tempered by very expensive valuation (extremely high P/E), recent margin compression, and mixed balance-sheet/leverage signals, with technicals supportive but somewhat stretched.
Positive Factors
Strong free cash flow generation
Robust and growing free cash flow underpins durable financial flexibility: supports R&D spending, debt paydown (term loan repaid), capital returns and strategic M&A integration without stressing operations. High FCF conversion versus earnings demonstrates earnings quality and resilience over the medium term.
Negative Factors
Elevated absolute debt and mixed leverage signals
A high absolute debt load constrains financial flexibility for further acquisitions, buybacks, or countercyclical investment if end markets soften. Mixed leverage trends across reporting periods reduce confidence in deleveraging momentum and increase sensitivity to cash generation and interest costs over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong free cash flow generation
Robust and growing free cash flow underpins durable financial flexibility: supports R&D spending, debt paydown (term loan repaid), capital returns and strategic M&A integration without stressing operations. High FCF conversion versus earnings demonstrates earnings quality and resilience over the medium term.
Read all positive factors

Synopsys (SNPS) vs. SPDR S&P 500 ETF (SPY)

Synopsys Business Overview & Revenue Model

Company Description
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform th...
How the Company Makes Money
Synopsys primarily makes money by selling (1) software tools and (2) semiconductor IP, with additional revenue from (3) services and (4) software integrity/security offerings. 1) EDA software licensing and related maintenance/support - Synopsys s...

Synopsys Key Performance Indicators (KPIs)

Any
Any
Revenue by Type
Revenue by Type
Breaks down revenue streams, highlighting which product or service types contribute most to the company’s top line and potential areas for growth.
Chart InsightsSynopsys's Products revenue shows a consistent upward trend, reflecting strong demand and strategic growth initiatives. The Maintenance and Services segment, however, experienced a significant spike in 2025, likely driven by the successful integration of ANSYS and increased demand for AI-driven solutions. The earnings call highlights a strategic partnership with NVIDIA and a positive outlook for FY 2026, despite challenges in China and a decline in the Design IP segment. These developments suggest Synopsys is well-positioned for continued growth, leveraging AI and strategic partnerships to enhance its market position.
Data provided by:The Fly

Synopsys Earnings Call Summary

Earnings Call Date:Feb 25, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:May 20, 2026
Earnings Call Sentiment Positive
The call emphasized a strong start to FY'26 with revenue at the high end of guidance, a material non-GAAP EPS beat, high non-GAAP margins, robust free cash flow and sizeable backlog. Integration of Ansys is already contributing meaningful revenue and is expected to drive cross-sell and joint-solution monetization over time, while the company is pursuing $400M run-rate revenue synergies and accelerating cost synergies. On the downside, Design IP is in a transitional phase with a ~6% YoY revenue decline, depressed IP margins and some timing/delivery risk for new IP titles. China headwinds and softer consumer/auto/industrial design starts add regional and end-market pressure. Overall, the positive operational execution, strong cash generation, and Acceleration from Ansys integration outweigh the near-term IP and China-related challenges.
Positive Updates
Top-Line Beat and Strong Quarter Start
Q1 total revenue of $2.41 billion came in at the high end of guidance, driven in part by approximately $886 million of Ansys revenue; company reiterated full-year revenue guidance of $9.56B–$9.66B.
Negative Updates
Design IP Revenue Decline and Transitional Year
Design IP revenue was $407 million, down approximately 6% year-over-year and flat sequentially; management reiterated FY'26 will be a transitional year for IP with muted growth expected.
Read all updates
Q1-2026 Updates
Negative
Top-Line Beat and Strong Quarter Start
Q1 total revenue of $2.41 billion came in at the high end of guidance, driven in part by approximately $886 million of Ansys revenue; company reiterated full-year revenue guidance of $9.56B–$9.66B.
Read all positive updates
Company Guidance
Synopsys reiterated full‑year targets while raising non‑GAAP EPS and provided detailed Q1/Q2 metrics: Q1 revenue was $2.41B (Ansys ~$886M), backlog $11.3B, total cash & short‑term investments $2.2B, total debt $10B (term loans of $4.3B repaid), GAAP EPS $0.34 and non‑GAAP EPS $3.77, non‑GAAP operating margin 42.1% (Q1 non‑GAAP costs $1.4B), free cash flow ~$822M; by segment Design Automation revenue was ~$2.0B with a 47.3% adjusted operating margin and Design IP was $407M (‑6% y/y) with a 16.2% margin. Full‑year guidance: revenue $9.56B–$9.66B (Ansys ~$2.9B at midpoint, growing double digits), GAAP costs $8.46B–$8.60B, non‑GAAP costs $5.69B–$5.75B (non‑GAAP operating margin ~40.5% at midpoint), GAAP EPS $2.21–$2.62, non‑GAAP EPS $14.38–$14.46 (up $0.06), operating cash flow ~$2.2B, CapEx ~$300M, and free cash flow ~$1.9B; Q2 targets: revenue $2.225B–$2.275B, GAAP costs $2.02B–$2.085B, non‑GAAP costs $1.38B–$1.41B, GAAP EPS $0.23–$0.43 and non‑GAAP EPS $3.11–$3.17, and the Board authorized up to $2B in share repurchases.

Synopsys Financial Statement Overview

Summary
Strong overall fundamentals led by high gross margins (~75%) and very strong, improving free cash flow (TTM FCF up sharply and ~93% of net income). Offsetting this, TTM profitability has softened (net margin down to ~14% from ~19% previously) and the balance sheet signals are mixed (inconsistent leverage metrics and lower recent ROE).
Income Statement
78
Positive
Balance Sheet
62
Positive
Cash Flow
84
Very Positive
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue8.01B7.05B6.13B5.32B4.62B4.20B
Gross Profit6.02B5.43B4.88B4.29B3.72B3.34B
EBITDA2.64B2.50B1.85B1.56B1.33B1.01B
Net Income1.10B1.33B2.26B1.23B984.59M757.52M
Balance Sheet
Total Assets47.24B48.22B13.07B10.33B9.42B8.75B
Cash, Cash Equivalents and Short-Term Investments2.20B2.96B4.05B1.59B1.57B1.58B
Total Debt10.04B14.29B684.46M677.60M656.37M666.77M
Total Liabilities16.69B19.90B4.05B4.15B3.86B3.45B
Stockholders Equity30.55B28.33B8.99B6.15B5.52B5.30B
Cash Flow
Free Cash Flow2.28B1.35B1.28B1.51B1.60B1.40B
Operating Cash Flow2.44B1.52B1.41B1.70B1.74B1.49B
Investing Cash Flow-15.90B-15.91B1.22B-482.10M-572.62M-549.03M
Financing Cash Flow11.80B13.39B-181.30M-1.20B-1.12B-748.75M

Synopsys Technical Analysis

Technical Analysis Sentiment
Positive
Last Price449.58
Price Trends
50DMA
422.34
Positive
100DMA
448.07
Positive
200DMA
483.12
Negative
Market Momentum
MACD
2.52
Negative
RSI
63.62
Neutral
STOCH
90.09
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNPS, the sentiment is Positive. The current price of 449.58 is above the 20-day moving average (MA) of 410.07, above the 50-day MA of 422.34, and below the 200-day MA of 483.12, indicating a neutral trend. The MACD of 2.52 indicates Negative momentum. The RSI at 63.62 is Neutral, neither overbought nor oversold. The STOCH value of 90.09 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SNPS.

Synopsys Risk Analysis

Synopsys disclosed 29 risk factors in its most recent earnings report. Synopsys reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Synopsys Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$99.21B14.2462.31%10.96%12.71%
74
Outperform
$145.69B71.1815.49%15.43%-2.40%
72
Outperform
$62.41B31.84123.64%14.17%7.23%
69
Neutral
$95.94B287.804.57%31.91%-52.44%
67
Neutral
$21.79B-232.70-3.48%23.91%-326.25%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
57
Neutral
$498.36B27.8957.35%1.00%14.87%29.81%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SNPS
Synopsys
498.54
37.77
8.20%
ADBE
Adobe
239.31
-131.67
-35.49%
FTNT
Fortinet
85.67
-18.54
-17.79%
ORCL
Oracle
172.96
33.57
24.08%
PANW
Palo Alto Networks
182.90
-3.75
-2.01%
ZS
Zscaler
134.11
-89.74
-40.09%

Synopsys Corporate Events

Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Synopsys Shareholders Approve Amended Equity Incentive Plan
Positive
Apr 20, 2026
At its April 16, 2026 annual meeting, Synopsys shareholders approved an amended and restated equity incentive plan that, for the first time, makes non-employee directors eligible for equity awards alongside executive officers, reinforcing equity-b...
Business Operations and StrategyStock Buyback
Synopsys Launches $250 Million Accelerated Share Repurchase
Positive
Mar 2, 2026
On March 2, 2026, Synopsys announced it had entered into a $250 million accelerated share repurchase agreement with The Bank of Nova Scotia to buy back its common stock. The move underlines the company’s capital return strategy and could sig...
Business Operations and StrategyStock BuybackFinancial Disclosures
Synopsys Posts Strong Q1 Results, Expands Buyback Program
Positive
Feb 25, 2026
On Feb. 25, 2026, Synopsys reported first-quarter fiscal 2026 revenue of $2.409 billion, up from $1.455 billion a year earlier, with GAAP EPS of $0.34 and non-GAAP EPS of $3.77, both at or above guidance. Management highlighted strong execution, a...
Business Operations and StrategyExecutive/Board Changes
Synopsys Updates Board as Part of Governance Refresh
Positive
Feb 19, 2026
On February 14, 2026, Synopsys’ board expanded from eleven to twelve members and appointed former Deloitte executive Peter A. Shimer as an independent director and audit committee member, effective immediately. Shimer, an audit committee fin...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 21, 2026